Related Experiment Video
Updated: May 31, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
The Role of Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock-Part 1:
Haris Patail1, Tanya Sharma2, Swati Chand3
1Department of Cardiology, Westchester Medical Center, New York Medical College, Valhalla, NY, USA. Electronic address: https://twitter.com/harispatail.
Insights
Mechanical circulatory support (MCS) may not improve survival in acute myocardial infarction with cardiogenic shock (AMI-CS). Patient selection and multidisciplinary care are crucial for optimizing outcomes in this high-mortality condition.
Area of Science:
- Cardiology
- Critical Care Medicine
- Medical Devices
Background:
- Acute myocardial infarction complicated by cardiogenic shock (AMI-CS) has a high mortality rate, even with modern revascularization techniques.
- The complex pathophysiology includes left ventricular dysfunction, inflammation, metabolic issues, and mechanical complications, often leading to multiorgan failure.
- Mechanical circulatory support (MCS) offers hemodynamic stabilization but its survival benefit in AMI-CS is debated, with landmark trials showing no mortality improvement.
Purpose of the Study:
- To review the current evidence and guidelines regarding the use of MCS in AMI-CS.
- To discuss practical considerations for optimizing patient outcomes with MCS.
- To highlight the importance of patient selection, timing, and multidisciplinary management.
Main Methods:
- Review of evolving evidence from clinical trials and studies.
- Analysis of updated clinical practice guidelines.
- Synthesis of practical considerations for MCS implementation.
Main Results:
- Landmark trials have not demonstrated a mortality benefit for MCS in AMI-CS.
- The role of MCS in AMI-CS remains a subject of ongoing debate.
- Optimizing outcomes hinges on careful patient selection, appropriate timing of intervention, and integrated multidisciplinary care.
Conclusions:
- Despite technological advancements, the survival benefit of MCS in AMI-CS is not definitively established.
- Effective management of AMI-CS requires a comprehensive approach focusing on patient selection, timely intervention, and coordinated multidisciplinary care.
- Further research is needed to clarify the optimal role and patient subgroups who may benefit most from MCS in AMI-CS.
Abstract:
Acute myocardial infarction complicated by cardiogenic shock (AMI-CS) carries high mortality despite improvement in contemporary revascularization. The pathophysiology is complex, involving impaired left ventricular function, systemic inflammation, metabolic derangements, and mechanical complications, which often progress to multiorgan failure. Mechanical circulatory support (MCS) devices provide temporary hemodynamic stabilization by unloading the left ventricle and maintaining systemic perfusion, but their role remains debated. Landmark trials have shown no mortality benefit with MCS. This review summarizes the evolving evidence, guideline updates, and practical considerations for MCS use in AMI-CS, emphasizing the importance of patient selection, timing, and multidisciplinary management in optimizing outcomes.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Pathophysiology of Heart Failure
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cardiomyopathy V: Interprofessional Care
